Skip to main content
Screener/Healthcare/Biotechnology

CAI — Caris Life Sciences, Inc.

NASDAQ
$15.77-0.33 (-2.02%)
Mid CapUnder $20HealthcareFastest GrowingLow Beta
$14.19
$42.50
$15.23
$16.14
EPS (TTM)$-1.51
P/E Ratio-452.83
Dividend Yield—
Market Cap$4.42B
Volume2.22M
Prev Close$16.09
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$216.2M-$510K$-0.000.0%-0.2%
Q4 '25$292.9M$82.0M$0.2875.4%28.0%
Q3 '25$216.8M$24.3M$0.0868.0%11.2%
Q2 '25$181.4M-$71.8M$-1.8762.7%-39.6%
Q1 '25$120.9M-$102.6M$-0.4047.2%-84.8%
Q2 '24$100.0M-$66.2M$-0.3537.5%-66.2%
Q1 '24$80.7M-$111.0M$-0.5332.4%-137.6%
Q3 '21$100.8M$51.2M$2.9253.6%50.7%
Get Your Daily Market Recap